Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed Here, we report the efficacy and safety of P + T in the overall MyPathway HER2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results